article thumbnail

STAT+: ‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices

STAT

But like any pharmaceutical company with an eye toward the future, Celgene continued to seek other ways to wring profits from its development work. Not long after the patent was awarded, the company leveraged federally funded research and began investigating different forms of the compound, called Revlimid.

FDA 122
article thumbnail

List of Top 10 Pharma Franchise Companies in India

Fossil Remedies

Wellona Pharma is a leading WHO , GMP certified manufacturer of pharmaceutical & healthcare products and well established name in the field as an exporter and supplier of pharmaceutical finished formulation products across the globe. Cubit Healthcare is a integrated franchise pharmaceutical company. Cubit Healthcare.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Precision Value & Health acquires Across Health

pharmaphorum

The company’s solutions are based around its proprietary Navigator365 product suite, which more than 40 pharmaceutical companies rely on for omnichannel planning and resource allocation.

article thumbnail

Amarin Makes Moves towards Global Expansion of Vazkepa

Pharmaceutical Technology

The pharmaceutical company is well on its way to achieving its goals with successful full reimbursements, already confirmed in the United Kingdom ( UK), and Sweden. AstraZeneca ’s cholesterol drug Crestor (rosuvastatin) was approved in 2003 in the US but only approved in Germany in 2008.

article thumbnail

Servier beefs up in cancer, buying Agios’ oncology business for $1.8bn

pharmaphorum

French pharmaceutical company Servier has swooped on Agios Pharma’s marketed and experimental cancer drugs, buying the entire franchise in a deal that leaves the US biopharma focused on genetic disorders.

article thumbnail

Former Sanofi head Viehbacher to become Biogen CEO

pharmaphorum

Viehbacher led Sanofi between 2008 and 2014 and has decades of experience with both large pharmaceutical companies and small biotechs. A veritable ‘industry veteran’, he spent 20 years at GSK before Sanofi, where he helped reshape the company’s drug portfolio.

article thumbnail

Halting Europe’s essential medicines manufacturing exodus

European Pharmaceutical Review

This left pharmaceutical companies in Europe with no European API supply source, and only a few suppliers in Asia. The last paracetamol plant in Europe, closed in France in 2008 as it was no longer economically sustainable, marking the exit of paracetamol manufacturing from Europe.